Cleanroom & Containment Facilities has delivered a new cleanroom manufacturing facility for Francicea at Venture House in Lichfield, giving the UK complementary and alternative therapy supplier its own in-house manufacturing capability for homeopathic products rather than relying solely on third-party production.

The project was completed in August 2026 following a six-month programme and includes a production cleanroom, a controlled, non-classified area for packaging and labelling, and supporting HVAC, purified water and production equipment, designed to align with Francicea's planned manufacturing operations and operational flows.

CCTech acted as technical adviser and validation consultant on the project, advising on cleanroom and HVAC requirements, GMP compliance, purified water and production equipment, and supporting the validation lifecycle and associated documentation strategy.

The Lichfield project follows CCF's delivery this month of a new NHS aseptic pharmacy unit in Portsmouth, where the company acted as design and build contractor and again worked with CCTech on validation and compliance.

Francicea, based in Lichfield and incorporated in 2018, is a UK supplier of complementary and alternative therapies with more than 30 years' industry experience among its team; the company operates an ISO 8 (Grade D) cleanroom using automated Korsakovian potentisation and is separately planning to add capsule manufacturing for food supplements.

Cleanroom & Containment Facilities specialises in the design and delivery of cleanrooms, containment facilities and controlled environments across pharmaceutical, healthcare and other regulated manufacturing sectors.

The project reflects a wider trend of complementary and alternative medicine suppliers bringing manufacturing in-house rather than outsourcing production, to gain closer control over quality, traceability and GMP compliance as the category professionalises.

The timing tracks continued growth in the UK's complementary and alternative medicine sector, where homeopathy sits within a group of therapies, including acupuncture, chiropractic and medical herbalism, accounting for around £544m in annual UK spending.

For the sector, specialist cleanroom design-build contractors such as CCF are benefiting from niche health and wellness suppliers needing pharma-grade manufacturing infrastructure without pharma-scale budgets, a market segment distinct from large-scale pharmaceutical facility projects.

The wider signal for the sector is that GMP-grade manufacturing infrastructure is becoming accessible to smaller, specialist health product suppliers rather than remaining the preserve of large pharmaceutical manufacturers, as demand for traceable, quality-assured complementary medicine grows.

Source: Cleanroom Technology / Francicea / Grand View Research